Assessing the Impact of Asthma: A Cross-Sectional Study in Workers Undergoing Therapy
- PMID: 40243550
- PMCID: PMC12120787
- DOI: 10.23749/mdl.v116i2.15786
Assessing the Impact of Asthma: A Cross-Sectional Study in Workers Undergoing Therapy
Abstract
Background: This study aimed to investigate the impact of asthma on work productivity among adults receiving asthma therapy.
Methods: A cross-sectional study involving 101 asthmatic patients treated at the Pulmonology Department of University Hospital in Mahdia (Tunisia) who had been employed for at least six months was conducted over the course of a year. Recruited patients were asked to complete a self-administered questionnaire that consisted of the Simplified Medication Adherence Questionnaire (SMAQ), the Work Productivity and Activity Impairment (WPAI), and the Pichot questionnaire.
Results: The study's participants had a sex ratio of 0.51 and a mean age of 44.1±13.2 years. Exposure to aerocontaminants was high among 64.4% of patients. The majority of the patients were treated with inhaled corticosteroids (ICS) and long-acting beta-agonists (LABA) (54.4%), and nearly half were classified as having moderate asthma. Our findings revealed significant challenges faced by these patients, with 62.4% experiencing poorly controlled or uncontrolled asthma. Additionally, 69.3% were non-adherent to treatment, and 71.3% reported worsening symptoms while at work. They worked an average of 38.3±16.4 hours per week. The impact of general health status on work productivity was measured at 3.3±2.5. Absenteeism and presenteeism rates were 4.2% and 33.1%, respectively, resulting in a productivity loss of 30.4%. Activity impairment was associated with factors such as gender, alcohol consumption, and uncontrolled asthma.
Conclusion: Addressing asthma control, working conditions, and mental health emerges as essential strategies to enhance workplace productivity. When evaluating the effectiveness of interventions among active asthmatic patients, presenteeism, absenteeism, and productivity loss should be considered.
Conflict of interest statement
There is no conflict of interest to declare.
The authors declare no conflict of interest.
Similar articles
-
The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the United Kingdom: a cross-sectional analysis.NPJ Prim Care Respir Med. 2017 Mar 9;27(1):17. doi: 10.1038/s41533-017-0014-1. NPJ Prim Care Respir Med. 2017. PMID: 28270657 Free PMC article.
-
Burden of asthma among patients adherent to ICS/LABA: A real-world study.J Asthma. 2019 Mar;56(3):332-340. doi: 10.1080/02770903.2018.1455858. Epub 2018 Apr 6. J Asthma. 2019. PMID: 29624458
-
Asthma control in patients treated with inhaled corticosteroids and long-acting beta agonists: A population-based analysis in Germany.Respir Med. 2016 Sep;118:58-64. doi: 10.1016/j.rmed.2016.07.012. Epub 2016 Jul 16. Respir Med. 2016. PMID: 27578472
-
Drug utilization and asthma control among young Danish adults with asthma. Analyses of trends and determinants.Dan Med J. 2012 Aug;59(8):B4501. Dan Med J. 2012. PMID: 22849986 Review.
-
Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma.Cochrane Database Syst Rev. 2021 May 4;5(5):CD013518. doi: 10.1002/14651858.CD013518.pub2. Cochrane Database Syst Rev. 2021. PMID: 33945639 Free PMC article.
References
-
- Global initiative for Asthma. Global strategy for Asthma Management and Prevention. 2022 Available online: https://ginasthma.org/gina-reports/ (Accessed on 28 Dec 2023).
-
- Reddel HK, Bacharier LB, Bateman ED, et al. Global initiative for asthma strategy 2021. Executive summary and rationale for key changes. Arch Bronconeumol. 2022;58(1):35–51. Doi: 10.1016/j.arbres.2021.10.003. - PubMed
-
- Masoli M, Fabian D, Holt S, Beasley R. Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 2004;59(5):469–78. Doi: 10.1111/j.1398-9995.2004.00526.x. - PubMed
-
- Ebmeier S, Thayabaran D, Braithwaite I, Bénamara C, Weatherall M, Beasley R. Trends in international asthma mortality: analysis of data from the WHO Mortality Database from 46 countries (1993-2012). Lancet. 2017;390(10098):935–45. Doi: 10.1016/S0140-6736(17)31448-4. - PubMed
-
- Kwas H, Guermazi E, Zendah I, Khattab A, Khouaja I, Ghédira H. L’asthme allergique en Tunisie. Rev Mal Respir. 2016;(Suppl 33):A77. Doi: https://doi.org/10.1016/j.rmr.2015.10.082.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical